Pyridoxal isonicotinoyl hydrazone: an effective iron-chelator after oral administration.
Brittenham
G M
GM
Case Western Reserve University, School of Medicine, Cleveland, OH.
D000284:Administration, Oral; D000818:Animals; D004311:Double-Blind Method; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006801:Humans; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D007538:Isoniazid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011730:Pyridoxal / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
D007502:Iron Chelating Agents; D011730:Pyridoxal; C021079:pyridoxal isonicotinoyl hydrazone; D007538:Isoniazid